← FDA DRUG APPROVALS

FDA ANDA · ANDA209074

MINOXIDIL

minoxidil foam 5% (womens)

Sponsor: TARO

APPLICATION
ANDA209074
TYPE
ANDA
ORIGINAL APPROVAL
2018-12-31
LATEST ACTION
2019-12-04
ROUTE
TOPICAL
DOSAGE FORM
AEROSOL, FOAM
MARKETING STATUS
Over-the-counter

Products

MINOXIDIL (FOR MEN)Over-the-counter
MINOXIDIL 5% · AEROSOL, FOAM · TOPICAL
MINOXIDIL (FOR WOMEN)Over-the-counter
MINOXIDIL 5% · AEROSOL, FOAM · TOPICAL

Approval history

2019-12-04Labeling · Supplement 1 · standardAP
2019-12-04Labeling · Supplement 2 · standardAP
2019-04-22UNKNOWN · Original · standardLetterAP
2018-12-31UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →